207 related articles for article (PubMed ID: 37805563)
1. Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective.
Backeljauw PF; Andrews M; Bang P; Dalle Molle L; Deal CL; Harvey J; Langham S; Petriczko E; Polak M; Storr HL; Dattani MT
Orphanet J Rare Dis; 2023 Oct; 18(1):312. PubMed ID: 37805563
[TBL] [Abstract][Full Text] [Related]
2. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
3. Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.
Pignolo RJ; Bedford-Gay C; Cali A; Davis M; Delai PLR; Gonzales K; Hixson C; Kent A; Newport H; Robert M; Scott C; Kaplan FS
Orphanet J Rare Dis; 2022 Apr; 17(1):168. PubMed ID: 35436894
[TBL] [Abstract][Full Text] [Related]
4. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.
Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V
Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome.
Bang P; Woelfle J; Perrot V; Sert C; Polak M
Eur J Endocrinol; 2021 Feb; 184(2):267-276. PubMed ID: 33434161
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
Kemp SF
BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
[TBL] [Abstract][Full Text] [Related]
7. Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes.
Andrews A; Maharaj A; Cottrell E; Chatterjee S; Shah P; Denvir L; Dumic K; Bossowski A; Mushtaq T; Vukovic R; Didi M; Shaw N; Metherell LA; Savage MO; Storr HL
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4716-e4733. PubMed ID: 34136918
[TBL] [Abstract][Full Text] [Related]
8. Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I).
Breil T; Kneppo C; Bettendorf M; ; Müller HL; Kapelari K; Schnabel D; Woelfle J
J Pediatr Endocrinol Metab; 2018 Aug; 31(8):895-902. PubMed ID: 29995632
[TBL] [Abstract][Full Text] [Related]
9. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Primary IGF-1 Deficiency in a Cohort of Canadian Children with Short Stature Using a Novel Algorithm Tailored to Electronic Medical Records.
Haridas R; Baxter C; Dover S; Goldbloom EB; Terekhov I; Robinson ME
Children (Basel); 2024 Jun; 11(6):. PubMed ID: 38929306
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
13. Short stature related to Growth Hormone Insensitivity (GHI) in childhood.
Mastromauro C; Giannini C; Chiarelli F
Front Endocrinol (Lausanne); 2023; 14():1141039. PubMed ID: 37008935
[TBL] [Abstract][Full Text] [Related]
14. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of primary insulin-like growth factor-I deficiency: current perspectives and clinical update.
Backeljauw P; Bang P; Clayton PE; Geffner M; Woods KA
Pediatr Endocrinol Rev; 2010 Feb; 7 Suppl 1():154-71. PubMed ID: 20463651
[TBL] [Abstract][Full Text] [Related]
16. IGFs and IGFBPs in GH insensitivity.
Savage MO; Blair JC; Jorge AJ; Street ME; Ranke MB; Camacho-Hübner C
Endocr Dev; 2005; 9():100-106. PubMed ID: 15879692
[TBL] [Abstract][Full Text] [Related]
17. Therapy with recombinant human IGF-1 for children with primary insulin-like growth factor-I deficiency.
Backeljauw P
Growth Horm IGF Res; 2020 Apr; 51():22-26. PubMed ID: 31982729
[TBL] [Abstract][Full Text] [Related]
18. Targeted Resequencing of Putative Growth-Related Genes Using Whole Exome Sequencing in Patients with Severe Primary IGF-I Deficiency.
Grosse G; Hilger A; Ludwig M; Reutter H; Lorenzen F; Even G; Holterhus PM; Woelfle J;
Horm Res Paediatr; 2017; 88(6):408-417. PubMed ID: 29073591
[TBL] [Abstract][Full Text] [Related]
19. Postprandial hyperglycemia corrected by IGF-I (Increlex®) in Laron syndrome.
Latrech H; Simon A; Beltrand J; Souberbielle JC; Belmejdoub G; Polak M
Horm Res Paediatr; 2012; 78(3):193-200. PubMed ID: 22986916
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation.
Chatterjee S; Shapiro L; Rose SJ; Mushtaq T; Clayton PE; Ten SB; Bhangoo A; Kumbattae U; Dias R; Savage MO; Metherell LA; Storr HL
Eur J Endocrinol; 2018 May; 178(5):481-489. PubMed ID: 29500309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
